People
At a recent Demy-Colton Virtual Salon, Michael Gaito, head of healthcare investment banking at J.P. Morgan, discussed the strength of capital raises despite COVID-19 and the resilient state of the biotech sector in the run-up to the Presidential election in November and the virtual J.P. Morgan Healthcare Conference (and the virtual Biotech Showcase) in January, with Dennis Purcell, founder of Aisling Capital LLC.
The importance of diversity of patients in clinical studies cannot be overlooked, nor can the importance of diversity at the C-suite level. But, it’s equally important to have a diverse clinical research team as well.
Barry Bloom, Ph.D., research professor of public health and former dean at the Harvard T.H. Chan School of Public Health, participated in an online forum titled “The Coronavirus Pandemic: Global Race for a Vaccine” held September 15.
On Face the Nation, Gottlieb said hospitalization rates in the United States for COVID-19 had been in a state of decline, but those numbers are now rising, which goes hand in hand with an increase in infection rates.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers and Shakers.
The move was announced due to the advisor’s role in overseeing a clinical study for Moderna’s mRNA vaccine candidate.
Competition for resources is growing, and the usual supply chain partners may not have available capacity in the preferred timeframe.
Last week, HHS Secretary Alex Azar assumed all final authority in deciding new rules regarding food, medical devices and new medications.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Cidara Therapeutics is hoping that its novel approach to influenza will prevent future “twindemic” double threats like the one we may face this year.
PRESS RELEASES